Capstone Investment Advisors
ACHN

Capstone Investment Advisors’s Achillion Pharmaceuticals ACHN Stock Holding History

Capstone Investment Advisors’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-299,906
Closed -$1.81M – 1451
2019
Q4 		$1.81M Buy
+299,906
New +$1.74M 0.01% 859
2016
Q4 		– Sell
-50,700
Closed -$410K – 1182
2016
Q3 		$410K Buy
+50,700
New +$431K 0.01% 548

Capstone Investment Advisors's ACHN Position: Q1 2020 in Review

Capstone Investment Advisors sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 299,906 shares — an estimated $1.81M sold.

Capstone Investment Advisors first reported a position in ACHN in Q3 2016 and held it in 2 quarters. The position peaked at $1.81M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • Capstone Investment Advisors reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Capstone Investment Advisors sold 299,906 Achillion Pharmaceuticals shares in Q1 2020, an estimated $1.81M.
  • Capstone Investment Advisors first reported a position in Achillion Pharmaceuticals in Q3 2016 and held it in 2 quarters.
  • Capstone Investment Advisors's Achillion Pharmaceuticals position peaked at $1.81M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Capstone Investment Advisors's 13F filing for Q1 2020, filed 15 May 2020.